• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boundless Bio, Inc. - Common Stock (NQ:BOLD)

2.600 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boundless Bio, Inc. - Common Stock

< Previous 1 2 Next >
These stocks are moving in today's session ↗
June 23, 2026
Via Chartmill
Which stocks are experiencing notable movement on Tuesday? ↗
June 23, 2026
Via Chartmill
News headline image
BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders
June 23, 2026
From Halper Sadeh LLC
Via Business Wire
The market is filled with gapping stocks in Tuesday's session. ↗
June 23, 2026
Via Chartmill
What's going on in today's pre-market session ↗
June 23, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
June 23, 2026
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million. Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to... 
Via Benzinga
News headline image
Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
June 23, 2026
From Boundless Bio, Inc.
Via GlobeNewswire
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Targets Next Wave of DNA Damage Response Cancer Therapies
June 22, 2026
Via Investor Brand Network
Topics Artificial Intelligence
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
June 22, 2026
Via Investor Brand Network
News headline image
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
May 08, 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
April 17, 2026
Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers 
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Tuesday's session: gap up and gap down stocks ↗
April 14, 2026
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
March 17, 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 09, 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Leerink Global Healthcare Conference
March 04, 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
January 20, 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
November 05, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio (BOLD) Q2 R&D Drops 17% ↗
August 05, 2025
Via The Motley Fool
News headline image
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
August 05, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Announces Portfolio Prioritization and Runway Extension
May 23, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
May 09, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
April 03, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
March 27, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Leerink Global Healthcare Conference
February 26, 2025
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
February 03, 2025
- Dr. Doebele has over 15 years of oncology drug development experience as a public company Chief Medical Officer and clinical researcher at leading cancer centers - 
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Announces Pipeline and Leadership Updates
December 12, 2024
From Boundless Bio, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap